Jiangsu Hengrui Medicine Co., Ltd.

Overview

Jiangsu Hengrui Medicine Co., Ltd. is a leading pharmaceutical company in China, focused on the research, development, manufacturing, and distribution of innovative and generic pharmaceuticals, covering a variety of therapeutic areas with a strong emphasis on oncology, cardiovascular, and anesthesiology products.

Therapeutic areas

API / Drug Master Files

Jiangsu Hengrui Medicine Co., Ltd. holds 0 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MESNA USP, NON-STERILE, BULK DRUG SUBSTANCEInactive2012-05-07
• AZELASTINE HYDROCHLORIDE, NON-STERILE, BULK DRUG SUBSTANCEInactive2011-12-23
• CAPECITABINE USP, NON-STERILE, BULK DRUG SUBSTANCEInactive2011-11-22
• SEVOFLURANE USP, NON-STERILE, BULK DRUG SUBSTANCEInactive2011-04-29
• TAMSULOSIN HYDROCHLORIDE USP, NON-STERILE, BULK SUBSTANCEInactive2010-04-07
• THIOTEPA USP NON STERILE BULK DRUGInactive1999-07-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Jiangsu Hengrui Medicine Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.